Artax Announces First Patient Dosed in Phase 2a Psoriasis Trial Evaluating AX-158
/PRNewswire/ -- Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of autoimmune diseases, today announces...
Source: prnewswire.com